Eremid® Genomic Services, LLC (“Eremid”) announces a significant expansion of its in-house sequencing capabilities with the installation of PacBio’s latest HiFi sequencing platform, the Revio.

Oncodesign Services announces the execution of a Preclinical License and Supply Agreement with ImaginAb Inc. for the use of their investigational CD8 ImmunoPET™ (89Zr crefmirlimab berdoxam) technology.

Cherwell has published findings of a new impartial investigation into the impact of using pre-poured Petri dishes from different suppliers for air sampling in cleanroom environmental monitoring programs.

The Knife Mill PULVERISETTE 11 provides a homogeneous sample in a very short time due to its special design.

Sphere Fluidics has announced updates to its flagship platform, Cyto-Mine®, enabling it to be compliant with current Good Manufacturing Practice regulations enforced by the US FDA.

According to two new studies, a pioneering scanning device can instantly reveal an individual’s risk of type 2 diabetes through a non-invasive fingernail reading.

Qkine is delighted to announce its collaboration with Sartorius to supply growth factors and cytokines for stem cell and organoid research, as part of a comprehensive workflow solution.

A new clinical trial of a ground-breaking phage-based molecular diagnostic, has been agreed. The trial is aimed at evaluating the performance of the phage assay as a first-line blood-based diagnostic for active pulmonary Tuberculosis.

Biotium is thrilled to announce the release of its latest product, Mix-n-Stain™ CF® Dye IgM Antibody Labeling Kits.

Bioscientia acquires multiple Revio sequencing systems to revolutionize rare disease research by sequencing thousands of long-read human genomes annually.